Specialty Urology
-
Featured
Options for Managing Post-prostatectomy Urinary Incontinence
With more treatment options available to radical prostatectomy patients who experience post-prostatectomy stress urinary incontinence, patients will continue to enjoy improvements in quality of life.
-
Innovations and Clinical Expertise in Female Voiding Dysfunction Management
Female voiding dysfunction (FVD) is a common multifactorial condition typified by abnormally slow or incomplete voiding of urine from the bladder. Elise De, MD, collaborates with a multidisciplinary team of experts to pave the way for innovative treatment methods for patients with FVD.
-
Review: Diagnosis and Management of Underactive Bladder in Women
What to know about the new consensus definition of underactive bladder and the special needs of women with this condition.
-
Gene Profiling of Bladder Tumors Shows Promise for Identifying Candidates for Trimodality Therapy
Research by Massachusetts General Hospital Cancer Center oncologists suggests gene profiling of tumors from patients with muscle-invasive bladder cancer can guide rational selection of those who will benefit most from bladder-preserving trimodality therapy.
-
New Research Shows MRI Can Differentiate Transurethral Bulking Agent from Serious Pathology
A patient's chart may not report a history of treatment with transurethral bulking agent, but differences in MRI signal intensity and lesion characteristics can distinguish bulking agent from urethral diverticula and periurethral cysts.
-
Enhanced Delivery System Improves Dwell Time of Drug for Interstitial Cystitis
A synthetic glycosaminoglycan, when combined with a novel polymer for enhanced intravesical delivery, was released in the bladders of mice for 24 hours, leading to reduced abdominal pain and inflammation.
Urology contributors
-
Adam Scott Feldman, MD, MPH
Director, Combined Harvard Urologic Oncology Fellowship
Recent Article
Comparative Effectiveness of Bladder-preserving Trimodality Therapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer
-
Ajay Nehra, MBBS
Director of Men's Health and Male Reconstructive Surgery, Senior Urologic Surgeon
Recent Article
Advances in Treatment for Peyronie's Disease
-
Ajay Singla, MD
Director, Harvard Urologic Surgery Residency Program
Recent Article
Review: Diagnosis and Management of Underactive Bladder in Women
-
Brian Howard Eisner, MD
Co-Director, Kidney Stone Program, Assistant Professor of Surgery, Harvard Medical School
Recent Article
Patients Without Evidence of Ureteral Stone Passage Should Seek Follow-up Imaging
-
Dianne E. Sacco, MD
Co-Director, Kidney Stone Program, Assistant Professor of Surgery, Harvard Medical School
-
Douglas Middleton Dahl, MD
Chief, Division of Urologic Oncology, Director of Robotic Surgery, Associate Professor, Harvard Medical School
Recent Article
Ultrasound Therapy Yields Promising Results for Localized Prostate Cancer
-
Elise J. De, MD
Urologist
Recent Article
Innovations and Clinical Expertise in Female Voiding Dysfunction Management
-
-
Matthew F. Wszolek, MD
Assistant in Urology, Massachusetts General Hospital, Instructor in Surgery, Harvard Medical School
Recent Article
New Clues Emerge on Management of Recurrent Nonmuscle Invasive Bladder Cancer After Trimodality Therapy
-
Shahin Tabatabaei, MD
Director, Prostate Health Program
Recent Article
BPH Supplements Have Little Support for Efficacy and Safety
-
Siam Oottamasathien, MD
Director of Pediatric Urology Basic Science Research
Recent Article
Enhanced Delivery System Improves Dwell Time of Drug for Interstitial Cystitis
Urology Care at Mass General
The Department of Urology at Massachusetts General Hospital offers sophisticated, compassionate care and the most innovative treatments for patients with any type of urological condition.Resource Links
